Optimization of the First Step of Enoxaparin Synthesis by Hydrolytic Depolymerization of Unfractionated Heparin


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The first step of low-molecular-mass heparin (enoxaparin) preparation by hydrolytic depolymerization of unfractionated heparin was investigated. The step involved chemical reaction of starting heparin and benzethonium chloride in aqueous saline solutions. The number of acid equivalents in unfractionated heparin was shown to increase as the NaCl concentration increased. This was probably related to effects of the solution ionic strength on the heparin macromolecular conformation, which was confirmed using dynamic light scattering. The average size of the observed light-scattering centers in aqueous heparin solutions decreased with increasing NaCl concentration. Rinsing with H2O and not NaCl solutions and application of ultrasonication were recommended to accelerate purification of benzethonium heparinate from starting materials and to reduce the amount of rinse water. The compositions of the produced and purified benzethonium heparinate samples were confirmed using PMR spectroscopy.

Sobre autores

L. Frumin

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Autor responsável pela correspondência
Email: leflab39@mail.ru
Rússia, Moscow, 119571

K. Yur’eva

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
Rússia, Moscow, 119571

A. Askretkov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
Rússia, Moscow, 119571

D. Prokhorov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
Rússia, Moscow, 119571

A. Matveev

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
Rússia, Moscow, 119571

E. Zhavoronok

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
Rússia, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

A. Panov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
Rússia, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

D. Shatalov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
Rússia, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

E. Shnyak

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
Rússia, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

S. Kedik

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
Rússia, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies